trial

Artificial Intelligence to Measure Adherence to Oral Medication

NCTId NCT04046497
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Recruiting
Enrollment 200 (estimated)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2024-11-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Recruiting
Enrollment
200 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2020-11-20
Primary completion
2024-11-30
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
Smartphone App

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

5 total
Hialeah, United StatesGrand Rapids, United StatesKalamazoo, United StatesOklahoma City, United StatesTulsa, United States

Facts & assertions

4 sourced
Enrollment
200
Phase
PHASE4
Primary Completion Date
2024-11-30
Status
RECRUITING
relationships
The graph out of here
drug
Smartphone App
drug
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
First Episode Psychosis
indication